{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:41:53Z","timestamp":1791956513344,"version":"4.3.4"},"reference-count":20,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Society of Pediatric Dermatology Pilot Project grant."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background\/Objective<\/jats:title><jats:p>The isothiazolinones methylchloroisothiazolinone (<jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>) and methylisothiazolinone (<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content>) are prevalent pediatric contact sensitizers. <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> allergic contact dermatitis (<jats:styled-content style=\"fixed-case\">ACD<\/jats:styled-content>) is underreported in the literature. The objective of the current study was to use a database of provider\u2010reported U.S. pediatric patch test cases to evaluate the positive patch test (<jats:styled-content style=\"fixed-case\">PPT<\/jats:styled-content>) prevalence rates of the combined preservative test substrate <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> and of <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>U.S. pediatric patch test providers in all 50 states who had joined the registry were invited to submit deidentified cases to the database. More than 1100 logged cases in the database were evaluated for <jats:styled-content style=\"fixed-case\">PPT<\/jats:styled-content>s to <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> combination, <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Within 1 year of data collection, 96 cases with a <jats:styled-content style=\"fixed-case\">PPT<\/jats:styled-content> for <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> alone were identified; 37 of these were positive to <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content>, with <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> alone not tested or negative, and 39 were positive to <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> only, with <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> tested. Fifteen (41%) of the <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> cases were detected using an epicutaneous patch test alone and 22 cases (59%) using comprehensive patch testing. Only one case (3%) of <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> alone sensitization was detected using <jats:styled-content style=\"fixed-case\">T.R.U.E.<\/jats:styled-content> plus a supplemental panel of tests; the remaining 38 cases (97%) were detected using comprehensive testing. Testing with only the combined <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> preservative substrate may miss 51% of <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> allergies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Appropriate testing of isothiazolinones is needed to clarify the true prevalence of sensitization to these allergens and the burden of pediatric <jats:styled-content style=\"fixed-case\">ACD<\/jats:styled-content>. Patch testing for <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> alone in addition to <jats:styled-content style=\"fixed-case\">MCI<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> combination is warranted in children with recalcitrant dermatitis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/pde.13063","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T09:03:02Z","timestamp":1485162182000},"page":"138-143","source":"Crossref","is-referenced-by-count":11,"title":["Appropriate Testing of Isothiazolinones in Children"],"prefix":"10.1111","volume":"34","author":[{"given":"Alina","family":"Goldenberg","sequence":"first","affiliation":[{"name":"Department of Dermatology University of California at San Diego San Diego California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lipp","sequence":"additional","affiliation":[{"name":"Lake Erie Consortium for Osteopathic Medical Training (LECOMT)\/Larkin Community Hospital\u2010Palm Springs Campus Hialeah Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E.","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Dermatology Loma Linda University Loma Linda California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"JacobSB BantaMR.Focus on T.R.U.E. Test Allergen #17 Methylchloroisothiazolinone\/Methylisothiazolinone. Dermatologist.http:\/\/www.the-dermatologist.com\/article\/5879(accessed December 3 2016)."},{"key":"e_1_2_7_3_1","unstructured":"GadberryR.Ingredient Review: The Safety of Paraben Substitutes. Skin Inc. magazine.http:\/\/www.skininc.com\/skinscience\/ingredients\/17013151.html(accessed December 3 2016)."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91318-4"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12560"},{"key":"e_1_2_7_6_1","unstructured":"Dow Chemical Company.Preservatives for Household and Industrial Use: Highly Effective and Environmentally Sound Microbicides.http:\/\/www.dow.com\/microbial\/applications\/ma_rinseoff_app.htm(accessed December 3 2016)."},{"key":"e_1_2_7_7_1","unstructured":"Dow Chemical Company.NEOLONE\u2122 for Personal Care: Preservatives for Skin Sun and Hair Care Products.http:\/\/www.dow.com\/microbial\/applications\/ma_rinseoff_app.htm(accessed December 3 2016)."},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000152"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/132564"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.1.e3"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000061"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000083"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2011.11011"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1453"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12328"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000119"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000214"},{"key":"e_1_2_7_18_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2310\/6620.2008.08057","article-title":"Patch testing: the whole in addition to the sum of its parts is greatest","volume":"20","author":"Nijhawan RI","year":"2009","journal-title":"Dermatitis"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04277.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1997.tb00398.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0b013e31827edc73"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpde.13063","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.13063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T21:30:14Z","timestamp":1696023014000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.13063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,23]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1111\/pde.13063"],"URL":"https:\/\/doi.org\/10.1111\/pde.13063","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,23]]}}}